Aarhus University Seal / Aarhus Universitets segl

Michael Winterdahl

PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

We have previously developed (11)C-erlotinib as a new positron emission tomography (PET) tracer and shown that it accumulates in epidermal growth factor receptor (EGFR)-positive lung cancer xenografts in mice. Here, we present a study in patients with non-small cell lung cancer (NSCLC) investigating the feasibility of (11)C-erlotinib PET as a potential method for the identification of lung tumours accumulating erlotinib.
Original languageEnglish
JournalB J C
Pages (from-to)1850-5
Number of pages6
Publication statusPublished - 2011

    Research areas

  • Adult, Aged, Animals, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Mice, Middle Aged, Positron-Emission Tomography and Computed Tomography, Receptor, Epidermal Growth Factor, Treatment Outcome

See relations at Aarhus University Citationformats

ID: 44405587